2-amino-1,3,4-thiadiazole has been researched along with Leishmaniasis, American in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amaral, VF; Canto-Cavalheiro, MM; Charret, KS; da Silva, EF; Echevarria, A; Leon, LL; Rodrigues, RF | 1 |
Amaral, V; Campos, MC; Canto-Cavalheiro, MM; Charret, KS; Dos Reis, C; Echevarria, A; Leon, LL; Rodrigues, RF | 1 |
2 other study(ies) available for 2-amino-1,3,4-thiadiazole and Leishmaniasis, American
Article | Year |
---|---|
Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Blood Cell Count; Leishmania mexicana; Leishmaniasis, Cutaneous; Lymph Nodes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Nitric Oxide; Organometallic Compounds; Structure-Activity Relationship; Thiadiazoles | 2009 |
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thiadiazoles; Treatment Outcome | 2012 |